Cardio Diagnostics Holdings Inc. Common stock (CDIO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cardio Diagnostics Holdings Inc. Common stock, updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$1.70
0.00% today
Market cap
$5M
Overall quality
53/100
Kronos AI 30-day
+6.8%
8 of 8 simulated paths end higher
Cardio Diagnostics Holdings Inc. Common stock (CDIO) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $5M. It trades at $1.70, up 0.00% today. Its overall quality score is 53 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +6.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.81 (+6.8%) |
| Likely range | +0.4% … +16.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 92 |
| Growth | 28 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.